هفته نامه اطلاع رسانی اختراعات منتشر شده در سازمان جهانی مالکیت فکری
invbazaar.com

سالهفتهIDTitleApplNoIPCApplicantSubgroupزیر گروهرشته شرحDescription
202602WO/2025/217863GAS6 FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOFCN2024/088476C07K 19/00SUZHOU ROCROCK NO.1 BIOTECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2025/235413COMPOSITIONS TARGETING CANCER ANTIGENS AND METHODS OF USE THEREOFUS2025/027818C07K 16/28DUKE UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2025/240129OPTOGENETIC PROTEIN PRODUCTIONUS2025/027251C07K 14/39THE TRUSTEES OF PRINCETON UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2025/252023MODULATORS FOR GIPR, GLP1R AND/OR GCGR AND USES THEREOFCN2025/098369C07K 16/28FORTVITA BIOLOGICS INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2025/254978DECOY RECEPTOR 3 (DCR3) BINDING PROTEINS AND USES THEREOFUS2025/031838C07K 16/28WRENCH BIO, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/006882INHIBITORS OF FXIAAU2025/050720C07K 7/06THE UNIVERSITY OF SYDNEYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/006883FXI MODULATORSAU2025/050721C07K 7/08THE UNIVERSITY OF SYDNEYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/006884MODULATORS OF FXII-UPARAU2025/050722C07K 7/08THE UNIVERSITY OF SYDNEYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007063α-CONOTOXIN PEPTIDE LVID MUTANT, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOFCN2024/103589C07K 14/435GUANGXI UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007196ANTIBODY SPECIFICALLY BINDING TO FGFR2B AND DRUG CONJUGATE THEREOFCN2024/110924C07K 16/28ABIOTECH PHARMACEUTICAL CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007374ENGINEERED GENE TRANSCRIPTIONAL REPRESSION TOOL TARGETING HEPATITIS B VIRUS GENE AND USE THEREOFCN2025/000022C07K 19/00EPIGENIC THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007411ANTI-IL1RL1/IL-33/NF-KB ANTIBODY AND METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING SAMECN2025/076806C07K 16/28GUANGZHOU MEDICAL UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007513CLAUDIN 18.2-TARGETING CHIMERIC ANTIGEN RECEPTOR FUSED WITH CHIMERIC SWITCH RECEPTOR, IMMUNE CELL MODIFIED THEREBY, AND USE THEREOFCN2025/091685C07K 19/00CARBIOGENE THERAPEUTICS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007560NANOBODY TARGETING FIBROBLAST ACTIVATION PROTEIN-α, AND USE THEREOFCN2025/095902C07K 16/40GUORUI (GUANGZHOU) BIOTECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007692APELIN-13 POLYPEPTIDE MUTANTCN2025/101651C07K 14/575ZHEJIANG UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007693APELIN-13 POLYPEPTIDE MUTANTCN2025/101655C07K 7/08ZHEJIANG UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007830CD7-TARGETING NANOBODY AND USE THEREOFCN2025/104398C07K 16/28SHENZHEN GENOCURY BIOTECH CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007893ANTIBODY TARGETING INTEGRIN α3β1 OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOFCN2025/105614C07K 16/28INXMED (NANJING) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007900VANCOMYCIN DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USECN2025/105688C07K 7/06SHANDONG LABORATORY OF YANTAI DRUG DISCOVERYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/007901FLT3-CAR-γδT CELL CO-EXPRESSING CYTOKINE AND USE THEREOFCN2025/105691C07K 19/00PERSONGEN BIOTHERAPEUTICS (SUZHOU) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008009PD-1 TARGETING ANTIBODIES AND USES THEREOFCN2025/106810C07K 16/28XIAMEN JIUHEYIPIN BIOPHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008012ANTI-BDCA2 ANTIBODY AND USE THEREOFCN2025/106822C07K 16/28BIORAY PHARMACEUTICAL (HANGZHOU) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008041ANTIGEN BINDING MOLECULE SPECIFICALLY BINDING TO LATENT-MYOSTATIN AND MEDICAL USE THEREOFCN2025/106996C07K 16/18JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008664ALLOSTERIC MODULATORS OF INHIBITORY IMMUNE RECEPTOR COMPLEXESEP2025/068743C07K 16/28VIB VZWCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008665BINDERS OF THE PD-1•PD-L1 COMPLEX AND THEIR USEEP2025/068744C07K 16/28VIB VZWCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008836GLP-1 DERIVATIVES AND USES THEREOFEP2025/069132C07K 14/605NOVO NORDISK A/SCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008845METHOD FOR PROVIDING A GLYPHOSATE TOLERANT BRYOPHYTEEP2025/069151C07K 14/415OXFORD UNIVERSITY INNOVATION LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008865PRODUCTS FOR USE IN THE TREATMENT AND PREVENTION OF ALLERGY AND LUNG CONDITIONS/DISEASES ASSOCIATED WITH AN ALLERGY OR WITH A PATHOGEN-DRIVEN IMMUNE RESPONSEEP2025/069197C07K 16/28T-BALANCE THERAPEUTICS GMBHCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/008979SOLUTION PHASE PEPTIDE SYNTHESISGB2025/051451C07K 1/02IMPERIAL COLLEGE INNOVATIONS LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009133ANTI-B7-H3 ANTIBODYIB2025/056636C07K 16/28DAIICHI SANKYO COMPANY, LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009167A MANUFACTURING PROCESS FOR ALBUMIN INVOLVING A HEATING STEPIB2025/056713C07K 14/765CSL BEHRING AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009243AN IMPROVED PROCESS FOR THE PREPARATION OF TIRZEPATIDE BY USING HYBRID APPROACHIN2025/050973C07K 14/00NEULAND LABORATORIES LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009637ANTIBODY SPECIFICALLY RECOGNIZING ECM1, METHOD FOR DETECTING DISEASE HAVING HIGH RISK OF FRACTURE USING SAME, AND DETECTION REAGENTJP2025/020601C07K 16/18PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009920METHOD FOR PURIFYING CYCLIC PEPTIDE AND METHOD FOR PRODUCING CYCLIC PEPTIDEJP2025/023820C07K 1/32CHUGAI SEIYAKU KABUSHIKI KAISHACHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/009984COMPOUND CONTAINING ANTIBODY AFFINITY POLYPEPTIDE, MODIFIED ANTIBODY, ANTIBODY DERIVATIVE, ANTIBODY-FUNCTIONAL SUBSTANCE CONJUGATE, AND SALTS OF THESEJP2025/024404C07K 14/315AJINOMOTO CO., INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010067ANTAGONISTIC ANTI-CD40 HUMANIZED ANTIBODYKR2025/003702C07K 16/28PB IMMUNE THERAPEUTICS, INCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010299PEPTIDE INHIBITOR FOR REMOVING SENESCENT CELLS, AND USE THEREOFKR2025/009272C07K 7/08GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010353NOVEL PRES1 DERIVATIVE COMPOUND INHIBITING HOST ENTRY OF HEPATITIS B VIRUSKR2025/009408C07K 14/005GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010398COMPOSITION FOR PREVENTING OR TREATING SEPSIS, COMPRISING PAPILIOCIN DERIVATIVE AS ACTIVE INGREDIENTKR2025/009522C07K 14/435KONKUK UNIVERSITY INDUSTRY-ACADEMY COOPERATION FOUNDATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010421DUAL TARGET FERRITIN-PROTEIN COMPLEX AND USE THEREOFKR2025/009574C07K 16/28CELLEMEDY CO.,LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010461FUSION PROTEIN FUSED WITH IGG FC DOMAIN AND COMPRISING LRRD2 OF SLIT3 PROTEIN, AND USE THEREOF FOR IMPROVING MUSCLE FUNCTION, ENHANCING MUSCLE STRENGTH, OR PREVENTING OR TREATING MUSCLE DISEASEKR2025/009694C07K 14/47DAEWOONG CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010581A COMBINATION THERAPY FOR THE TREATMENT OF NON-SMALL-CELL LUNG CANCERTR2024/050879C07K 16/28ISTANBUL MEDIPOL UNIVERSITESI TEKNOLOJI TRANSFER OFISI A.S.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010873EXPRESSION CASSETTE COMPRISING CODON-OPTIMIZED POLYNUCLEOTIDE ENCODING AFLIBERCEPT AND PLASMID FOR PRODUCING RAAV COMPRISING THE SAMEUS2025/035926C07K 14/475SAMSUNG BIOEPIS CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010900GENETICALLY ENGINEERED LIPOSWITCH-BASED NANOMATERIALSUS2025/036003C07K 14/00MOZHDEHI, DavoudCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010901PROCESS FOR PREPARING LIPIDATED PEPTIDE AND ITS INTERMEDIATESUS2025/036006C07K 7/04MERCK SHARP & DOHME LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010909SARS-COV2 ANTIBODIES AND METHODS OF USE THEREOFUS2025/036016C07K 16/08INVIVYD, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010947NEUTRALIZING ANTIBODIES AGAINST HIV ENVUS2025/036079C07K 16/10INTERNATIONAL AIDS VACCINE INITIATIVECHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/010982COMPOSITIONS AND METHODS FOR BINDING SRCUS2025/036126C07K 16/46THE REGENTS OF THE UNIVERSITY OF CALIFORNIACHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/0109865T4-BINDING PROTEINSUS2025/036132C07K 16/30SOLVE THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/011052CAR-T CELL THERAPY FOR TRIPLE NEGATIVE BREAST CANCERUS2025/036251C07K 16/28H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/011097ANTIBODY DRUG CONJUGATES COMPRISING TCR-VBETA SPECIFIC THERAPEUTIC MOLECULES AND USES THEREOFUS2025/036384C07K 14/705YALE UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/011103TCR-VΒETA SPECIFIC THERAPEUTIC MOLECULES AND USES THEREOFUS2025/036392C07K 16/28YALE UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202602WO/2026/011113ANTI-UREMIC TOXIN ANTIBODIES AND METHODS OF USE THEREOFUS2025/036413C07K 16/18NEW YORK UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی